GALT Return on Tangible Equity | GALECTIN THERAPEUTICS INC.

GALECTIN THERAPEUTICS INC. (GALT) Return on Tangible Equity

2026-06-30: Return Tang Equity 20.09%.
2026-03-31: Return Tang Equity 19.89%.
2025-12-31: Return Tang Equity 24.11%.
2025-09-30: Return Tang Equity 29.77%.

Complete source-backed return tang equity history.

Available history: 2010-12-31 to 2026-06-30
Data captured: 2026-09-04

Historical Return Tang Equity

Date	Return Tang Equity
2026-06-30	20.09%
2026-03-31	19.89%
2025-12-31	24.11%
2025-09-30	29.77%
2025-06-30	33.93%
2025-03-31	39.65%
2024-12-31	44.90%
2024-09-30	47.85%
2024-06-30	52.80%
2024-03-31	92.47%
2023-12-31	66.27%
2023-09-30	79.29%
2023-06-30	75.44%
2023-03-31	90.99%
2022-12-31	114.33%
2022-09-30	146.99%
2022-06-30	208.23%
2022-03-31	431.05%
2021-12-31	-3418.59%
2021-09-30	-414.02%
2021-06-30	-185.68%
2021-03-31	-158.97%
2020-12-31	-104.43%
2020-09-30	-69.59%
2020-06-30	-49.85%
2020-03-31	-35.28%
2019-12-31	-30.30%
2019-09-30	-23.47%
2019-06-30	-22.40%
2019-03-31	-234.75%
2018-12-31	-268.60%
2018-09-30	-182.64%
2018-06-30	-184.90%
2018-03-31	-1681.73%
2017-12-31	3063.21%
2017-09-30	-1947.62%
2017-06-30	-453.40%
2017-03-31	-247.38%
2016-12-31	-208.28%
2016-09-30	-208.79%
2016-06-30	-305.56%
2016-03-31	-176.40%
2015-12-31	-111.01%
2015-09-30	-148.71%
2015-06-30	-93.52%
2015-03-31	-70.97%
2014-12-31	-74.49%
2014-09-30	-63.99%
2014-06-30	-57.84%
2014-03-31	-49.51%
2013-12-31	-816.21%
2013-09-30	-897.31%
2013-06-30	350.02%
2013-03-31	1054.83%
2012-12-31	-830.47%
2012-09-30	-348.94%
2012-06-30	-203.95%
2012-03-31	-153.47%
2011-12-31	513.65%
2011-09-30	-1005.47%
2011-06-30	-803.93%

Annual Return Tang Equity

Date	Return Tang Equity
2025-12-31	24.11%
2024-12-31	44.90%
2023-12-31	66.27%
2022-12-31	114.33%
2021-12-31	-3418.48%
2020-12-31	-104.43%
2019-12-31	-30.30%
2018-12-31	-268.60%
2017-12-31	3063.21%
2016-12-31	-208.28%
2015-12-31	-111.01%
2014-12-31	-74.49%
2013-12-31	-816.21%
2012-12-31	-830.47%
2011-12-31	513.65%
2010-12-31	332.29%

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Arcturus Therapeutics Holdings Inc. (ARCT)		$0.402B	-2.05
Turn Therapeutics Inc. (TTRX)	United States	$0.397B	-25.68
Opus Genetics, Inc. (IRD)	United States	$0.406B	-3.16
RELMADA THERAPEUTICS, INC. (RLMD)	United States	$0.406B	-11.92
ARS Pharmaceuticals, Inc. (SPRY)	United States	$0.414B	-3.70
Atea Pharmaceuticals, Inc. (AVIR)	United States	$0.414B	-2.26
Rezolute, Inc. (RZLT)	United States	$0.382B	-6.45
DiaMedica Therapeutics Inc. (DMAC)	United States	$0.423B	-10.11
PROTHENA CORP PUBLIC LTD CO (PRTA)	Ireland	$0.428B	-11.53
CYPHERPUNK TECHNOLOGIES INC. (CYPH)	United States	$0.438B	-75.63